The effectiveness of pegylated interferon and ribavirin combination therapy for chronic hepatitis C in South Korea: a single center experience

被引：0
|
作者：
Kim, H. [1 ]
Cho, S. [1 ]
Han, J. [1 ]
机构：
[1] Catholic Univ Korea, Yeouido St Marys Hosp, Seoul, South Korea
来源：
JOURNAL OF VIRAL HEPATITIS | 2013年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：19 / 20
页数：2
相关论文
共 50 条
  • [41] COMPARATIVE STUDY OF MUTATIONS OF HCV IRES IS USEFUL FOR THE PREDICTION OF THE EFFECTIVENESS OF THE PEGYLATED INTERFERON/RIBAVIRIN COMBINATION THERAPY FOR CHRONIC HEPATITIS
    Ogata, Kei
    Ide, Tatsuya
    Arinaga, Teruko H.
    Koga, Yuriko
    Kuwahara, Reiichiro
    Miyajima, Ichiro
    Kumashiro, Ryukichi
    Sata, Michio
    [J]. HEPATOLOGY, 2010, 52 (04) : 824A - 824A
  • [42] Interferon (IFN) induction therapy in combination with ribavirin in chronic hepatitis C
    Ferenci, P
    Brunner, H
    Vogel, W
    Gschwantler, M
    Datz, C
    Hackl, F
    Steindl-Munda, P
    Hofer, H
    [J]. JOURNAL OF HEPATOLOGY, 2000, 32 : 38 - 38
  • [43] Combination therapy with interferon and ribavirin in the treatment of chronic hepatitis C infection
    Battaglia, AM
    Hagmeyer, KO
    [J]. ANNALS OF PHARMACOTHERAPY, 2000, 34 (04) : 487 - 494
  • [44] Mutagenic effects of ribavirin and response to interferon/ribavirin combination therapy in chronic hepatitis C
    Asahina, Y
    Izumi, N
    Enomoto, N
    Uchihara, M
    Kurosaki, M
    Onuki, Y
    Nishimura, Y
    Ueda, K
    Tsuchiya, K
    Nakanishi, H
    Kitamura, T
    Miyake, S
    [J]. JOURNAL OF HEPATOLOGY, 2005, 43 (04) : 623 - 629
  • [45] Significance of serum ribavirin concentration in combination therapy of interferon and ribavirin for chronic hepatitis C
    Arase, Y
    Ikeda, K
    Tsubota, A
    Suzuki, F
    Suzuki, Y
    Saitoh, S
    Kobayashi, M
    Akuta, N
    Someya, T
    Hosaka, T
    Sezaki, H
    Kobayashi, M
    Kumada, H
    [J]. INTERVIROLOGY, 2005, 48 (2-3) : 138 - 144
  • [46] Treatment of Chronic Hepatitis with Sofosbuvir in Combination with Ribavirin with or without Pegylated Interferon
    Sidhu, Sandeep S.
    Malhi, Nirmaljeet
    Singh, Rupinder
    Gover, Rajiv
    Sidhu, Js
    Bansal, Ajesh
    Goyal, Omesh
    Sidhu, Gursewak
    Nanda, Vijay
    Saluja, Harmeet
    Sehgal, Alok
    Simran, Sidhu
    Kishore, Harsh
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S383 - S383
  • [47] Pegylated interferon alfa and ribavirin for children with chronic hepatitis C
    Irit Rosen
    Michal Kori
    Orly Eshach Adiv
    Baruch Yerushalmi
    Nataly Zion
    Ron Shaoul
    [J]. World Journal of Gastroenterology, 2013, (07) : 1098 - 1103
  • [48] Safety and Efficacy of Combination Therapy with Pegylated Interferon Alpha-2a and Ribavirin in Treating Patients with Chronic Hepatitis C and Beta-Thalassaemia Major: A Greek Single-Center Experience
    Paschos, Paschalis
    Vlachaki, Efthimia
    Pasvanti, Chrisoula
    Sinakos, Emmanouil
    Kalpaka, Anastasia
    Klonizakis, Philippos
    Perifanis, Vasilios
    [J]. ACTA HAEMATOLOGICA, 2011, 126 (04) : 231 - 233
  • [49] Chronic hepatitis C: Retreatment of pegylated interferon/ribavirin nonresponders
    Cardoso, Helder
    Vale, Ana Horta
    Mendes, Margarida
    Bastos, Pedro
    Machado, Artur
    Santos, Carlos
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S192 - S193
  • [50] Chronic hepatitis C: Treatment of pegylated interferon/ribavirin nonresponders
    Shiffman M.L.
    [J]. Current Gastroenterology Reports, 2006, 8 (1) : 46 - 52
12345